Tag: William Blair

May 8, 2018

AxoGen Announces Proposed Public Offering of Common Stock

AxoGen (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced today that it has...
April 9, 2018

Carbon Black Files Registration Statement for Proposed Initial Public Offering

Carbon Black, a cybersecurity innovator and a leading provider of next-generation endpoint security announced it has publicly filed a registration...
January 25, 2018

Albireo Prices $65.0 Million Public Offering of Common Stock

Albireo Pharma (Nasdaq:ALBO) a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the pricing of...
January 22, 2018

BeiGene Announces Closing of $800 Million Public Offering

BeiGene (NASDAQ:BGNE) a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment...
January 19, 2018

BeiGene Announces Pricing of $750 Million Public Offering

BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment...
August 1, 2017

FDA Advisory Committee Sends Dynavax Stock Soaring

Dynavax Technologies saw its stock jump over 70 percent on Monday thanks to a favorable review from the US Food...
June 2, 2017

Tintri Files Registration Statement for Proposed Initial Public Offering

Tintri has announced that it has publicly filed a registration statement on Form S-1 with the Securities Exchange and Commission...